Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit Successfully Passed PEI Evaluation

Company news
2021-07-05

Another milestone! Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit has successfully passed the PEI evaluation. The results of the information can already be found on BfArm now, click here to know more.

 

Among the 542 special antigen products reviewed and filed by BfArm, only 1/3 of the products have passed the PEI assessment.

 

This is a further recognition of the quality of Bioperfectus diagnostic products.

 

Bioperfectus, working for a healthier life endlessly.

 

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14